A 58-year-old woman with hepatitis C virus (HCV) infection presents with progressive jaundice, ascites, and hepatic encephalopathy. Liver biopsy shows extensive fibrous septa dividing the liver parenchyma into irregular nodules, with loss of normal lobular architecture. Immunohistochemistry reveals activated hepatic stellate cells expressing α-smooth muscle actin (α-SMA). Which of the following best explains the role of stellate cell activation in the pathogenesis of cirrhosis in this patient?

Explanation

## Hepatic Stellate Cell Activation in Cirrhosis Pathogenesis **Key Point:** Hepatic stellate cell (HSC) activation is the central event in hepatic fibrogenesis. Activated stellate cells (myofibroblasts) are the primary source of excessive collagen deposition that leads to cirrhosis. ### Normal Stellate Cell Function In the normal liver, quiescent stellate cells: - Store retinoids (vitamin A) in lipid droplets - Maintain the extracellular matrix (ECM) - Regulate portal blood flow - Remain in a resting state in the space of Disse ### Activation Pathway in Chronic Liver Injury **High-Yield:** Any chronic liver injury (HCV, HBV, alcohol, NAFLD, autoimmune hepatitis) triggers the following sequence: 1. **Hepatocellular injury and inflammation** → Release of damage-associated molecular patterns (DAMPs) 2. **Paracrine signalling** → Activated hepatocytes and Kupffer cells release TGF-β, PDGF, and other cytokines 3. **Stellate cell activation** → HSCs transform from quiescent cells into proliferative myofibroblasts 4. **Phenotypic changes** → Loss of retinoid content, increased expression of α-SMA (α-smooth muscle actin), increased contractility 5. **Excessive collagen synthesis** → Activated HSCs produce types I and III collagen, overwhelming the normal ECM remodelling 6. **Fibrosis progression** → Fibrous septa form, nodules develop, normal architecture is lost → **Cirrhosis** ### Molecular Drivers of Activation | Factor | Source | Effect on HSCs | |--------|--------|----------------| | TGF-β | Kupffer cells, hepatocytes, platelets | Most potent activator; promotes differentiation to myofibroblasts | | PDGF | Platelets, endothelial cells | Promotes HSC proliferation and migration | | FGF | Hepatocytes | Enhances collagen synthesis | | Leptin | Adipose tissue, hepatocytes | Amplifies TGF-β signalling | | Reactive oxygen species (ROS) | Mitochondria, NADPH oxidase | Oxidative stress drives activation | **Clinical Pearl:** α-SMA is a marker of HSC activation. Its presence on immunohistochemistry indicates active myofibroblast differentiation and ongoing fibrogenesis. ### Pathological Consequences ```mermaid flowchart TD A[Chronic liver injury<br/>HCV, HBV, alcohol, NAFLD]:::outcome --> B[Hepatocyte injury<br/>Inflammation] B --> C[Release of TGF-β, PDGF<br/>Cytokine signalling]:::action C --> D[Hepatic stellate cell activation] D --> E[Transformation to myofibroblasts<br/>α-SMA expression]:::action E --> F[Excessive collagen I & III<br/>synthesis] F --> G[Fibrous septa formation<br/>Loss of architecture]:::outcome G --> H[Cirrhosis]:::outcome H --> I[Portal hypertension<br/>Hepatic dysfunction]:::urgent ``` **Mnemonic:** **STAR** = **S**tellate cell activation → **T**ransformation to myofibroblasts → **A**ctivation markers (α-SMA) → **R**esulting fibrosis and cirrhosis ### Why This Patient's Biopsy Shows α-SMA The presence of α-SMA-positive cells indicates: - Active HSC differentiation into myofibroblasts - Ongoing collagen synthesis - Progressive fibrogenesis - Advanced liver disease (consistent with clinical features: jaundice, ascites, encephalopathy) [cite:Robbins 10e Ch 18]